CNBX Pharmaceuticals Inc.
CNBX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001343009
No open-market purchases or sales by CNBX Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of CNBX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CNBX Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| 3i, LP | 13G/A | 9.90%169.3M shares | 0.00 ppfrom 9.90% | Mar 6, 202310 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on CNBX Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20265:00 PM ET | 3i, LPand 2 others | 13G/A | 9.90%169.3M shares | 0.00 ppfrom 9.90% | Jun 30, 2026 | SEC |
| May 8, 20265:07 PM ET | 3i, LPand 2 others | 13G/A | 9.90%124.9M shares | 0.00 ppfrom 9.90% | Mar 31, 2026 | SEC |
| Feb 5, 20264:07 PM ET | 3i, LPand 2 others | 13G/A | 9.90%83.6M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Nov 10, 20254:58 PM ET | 3i, LPand 2 others | 13G/A | 9.90%80.9M shares | 0.00 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Aug 13, 20254:05 PM ET | 3i, LPand 2 others | 13G/A | 9.90%13.6M shares | 0.00 ppfrom 9.90% | Jun 30, 2025 | SEC |
| May 13, 20259:06 PM ET | 3i, LPand 2 others | 13G/A | 9.90%3.42M shares | 0.00 ppfrom 9.90% | Mar 31, 2025 | SEC |
| Feb 13, 20254:06 PM ET | 3i, LPand 2 others | 13G/A | 9.90%3.41M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | 3i, LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | 3i, LP | 13G/AOld format | – | – | – | SEC |
| Mar 6, 2023 | 3i, LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CNBX Pharmaceuticals Inc. shares.
No Form 144 notices for CNBX Pharmaceuticals Inc. are on file.